Huilgol Shreya S, Berdahl Carl T, Qureshi Nabeel, Cohen Catherine C, Mendel Peter, Fischer Shira H
RAND Corporation, Boston, Massachusetts, USA.
RAND Corporation, Santa Monica, California, USA.
BMJ Innov. 2024 Jul;10(3):51-59. doi: 10.1136/bmjinnov-2023-001206. Epub 2024 Apr 25.
During a public health emergency like the COVID-19 pandemic, emergency department (ED) clinicians may be able to save more lives if they rapidly identify and implement innovations that are safe and effective. However, there is little research examining clinician decision-making around innovation implementation during public health emergencies and when evidence-based information is limited.
The goals of this study were to understand how ED clinicians decided to implement innovations and to describe the facilitators and challenges they faced during implementation.
We conducted 3 pilot interviews and 13 focus group discussions with clinicians from eight hospital-based EDs across the USA. Seventeen physicians, seven advanced practice providers, 18 nurses and seven respiratory therapists participated. We used inductive and deductive techniques to perform content and thematic analysis of focus group transcripts.
Participants cited social media, clinician autonomy, limited resources, organisational culture, supportive leadership and outside experiences as facilitators of trying innovations. Challenges in trying new innovations included limited evidence-based information, evolving guidelines, fear, moral distress and clinician pushback. Facilitators of using innovations in practice included leadership advocating for continued use, signs of patient improvement, ease of adoption and adequate resources. Challenges were the lack of familiarity, no established protocol and limited information dissemination about best practices.
Our study highlights factors that influenced innovation adoption and implementation in EDs during the COVID-19 pandemic, including how fear and moral distress affected decision-making. Organisations can support the implementation of promising innovations by selecting strong leaders, ensuring clinician psychological safety, providing protocols and resources and highlighting successes.
在像新冠疫情这样的突发公共卫生事件期间,如果急诊科临床医生能够迅速识别并实施安全有效的创新措施,他们或许能够挽救更多生命。然而,在突发公共卫生事件期间且循证信息有限的情况下,很少有研究考察临床医生围绕创新实施的决策过程。
本研究的目的是了解急诊科临床医生如何决定实施创新措施,并描述他们在实施过程中面临的促进因素和挑战。
我们对来自美国八家医院急诊科的临床医生进行了3次试点访谈和13次焦点小组讨论。17名医生、7名高级执业提供者、18名护士和7名呼吸治疗师参与其中。我们采用归纳和演绎技术对焦点小组记录进行内容和主题分析。
参与者提到社交媒体、临床医生自主性、资源有限、组织文化、支持性领导和外部经验是尝试创新的促进因素。尝试新创新的挑战包括循证信息有限、指南不断演变、恐惧、道德困扰和临床医生的抵制。在实践中使用创新的促进因素包括领导倡导持续使用、患者改善的迹象、易于采用和充足的资源。挑战在于缺乏熟悉度、没有既定方案以及关于最佳实践的信息传播有限。
我们的研究强调了在新冠疫情期间影响急诊科创新采用和实施的因素,包括恐惧和道德困扰如何影响决策。组织可以通过选拔强有力的领导者、确保临床医生的心理安全、提供方案和资源以及突出成功案例来支持有前景的创新措施的实施。